Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Dier Mardi
Relationship:  
City:   South San Francisco
State:   CA
   
Insider Summary:
  
   
Companies Owned :   6    
Direct Shares   101,126    

Indirect Shares

   875      
Direct Value   $4,683,687    

Indirect Value

   $3,544      
Total Shares   102,001      
Total Value   $4,687,231      


Adamas Pharmaceuticals Inc $82,200 Prelude Therapeutics Inc $0 Ultragenyx Pharmaceutical Inc $2,577,762 Acelyrin, Inc. $22,502 Madrigal Pharmaceuticals Inc $2,001,224 Adamas Pharmaceuticals Inc $82,200 Prelude Therapeutics Inc $0 Ultragenyx Pharmaceutical Inc $2,577,762 Acelyrin, Inc. $22,502 Madrigal Pharmaceuticals Inc $2,001,224
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    2   
    1    

     Stock price went up :
    0   
    1    
     Stock price went down :
    2   
    0    
   
     Gain/Loss Ratio :
   -2.0   
   1.0   
     Percentage Gain/Loss :
   -71.0%
 18.3%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Portola Pharmaceuticals Inc PTLA EVP and CFO 2020-07-02 0 0    Premium*  
            Adamas Pharmaceuticals Inc ADMS Director 2021-06-02 10,000 2020-06-03 0    Premium*  
            Prelude Therapeutics Inc PRLD Director 2020-09-29 10,000 2020-09-29 0    Premium*  
            Ultragenyx Pharmaceutical Inc RARE CFO & Executive Vice P... 2022-10-14 66,695 2020-10-12 0    Premium*  
            Acelyrin, Inc. SLRN CFO and CBO 2023-05-09 5,556 2023-05-09 875    Premium*  
            Madrigal Pharmaceuticals Inc MDGL 2024-03-11 8,875 0    Premium*  
* Premium Members only  

Records found :    73         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 2 of 3
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
PTLA Portola Pharmaceuticals I... Executive VP and CFO   •       –      –    2015-09-18 4 OE $5.10 $64,951 D/D 8,912 8,912 0 -
PTLA Portola Pharmaceuticals I... Executive VP and CFO   •       –      –    2015-05-11 4 OE $7.00 $118,596 D/D 13,674 13,674 0 -
PTLA Portola Pharmaceuticals I... Executive VP and CFO   •       –      –    2017-03-15 4 OE $7.00 $78,095 D/D 10,235 4,300 0 -
PTLA Portola Pharmaceuticals I... Executive VP and CFO   •       –      –    2017-06-27 4 OE $7.00 $1,736,009 D/D 93,392 6,885 0 -
PTLA Portola Pharmaceuticals I... EVP and CFO   •       –      –    2020-06-18 4 A $8.36 $84 D/D 10 10 0 -
PTLA Portola Pharmaceuticals I... Executive VP and CFO   •       –      –    2015-05-12 4 OE $9.50 $126,255 D/D 13,290 13,290 0 -
PTLA Portola Pharmaceuticals I... EVP, CFO & CBO   •       –      –    2020-03-02 4 D $9.68 $43,976 D/D (4,543) 78,229 0 -
PTLA Portola Pharmaceuticals I... EVP, CFO & CBO   •       –      –    2020-02-03 4 D $12.89 $44,277 D/D (3,435) 81,533 0 -
PTLA Portola Pharmaceuticals I... EVP, CFO & CBO   •       –      –    2020-01-14 4 D $13.80 $17,623 D/D (1,277) 68,718 0 -
PTLA Portola Pharmaceuticals I... EVP and CFO   •       –      –    2020-07-02 4 D $18.00 $712,314 D/D (39,573) 0 0 -
SLRN Acelyrin, Inc. CFO and CBO   •       –      –    2023-05-09 4 B $18.00 $100,008 D/D 5,556 5,556 2.74 %
SLRN Acelyrin, Inc. CFO and CBO   •       –      –    2023-05-09 4 B $18.00 $31,500 I/I 1,750 875 1.99 %
PRLD Prelude Therapeutics Inc Director   –       •      –    2020-09-29 4 B $19.00 $190,000 D/D 10,000 10,000 2.39 -
PTLA Portola Pharmaceuticals I... Executive VP and CFO   •       –      –    2014-05-29 4 AS $23.00 $115,000 D/D (5,000) 19,824 0 -
PTLA Portola Pharmaceuticals I... Executive VP and CFO   •       –      –    2014-07-25 4 AS $24.11 $120,568 D/D (5,000) 6,118 0 -
PTLA Portola Pharmaceuticals I... Executive VP and CFO   •       –      –    2014-04-25 4 AS $24.13 $120,725 D/D (5,000) 24,824 0 -
PTLA Portola Pharmaceuticals I... EVP, CFO & CBO   •       –      –    2019-01-15 4 D $24.25 $21,049 D/D (868) 97,932 0 -
PTLA Portola Pharmaceuticals I... Executive VP and CFO   •       –      –    2017-07-11 4 OE $25.08 $585,618 D/D 23,350 23,350 0 -
PTLA Portola Pharmaceuticals I... Senior VP and CFO   •       –      –    2014-03-25 4 AS $25.69 $128,433 D/D (5,000) 29,824 0 -
PTLA Portola Pharmaceuticals I... Executive VP and CFO   •       –      –    2014-08-25 4 AS $25.72 $131,314 D/D (5,000) 1,118 0 -
PTLA Portola Pharmaceuticals I... Interim Co-President & CFO   •       –      –    2018-08-23 4 D $26.05 $229,084 D/D (8,794) 107,477 0 -
PTLA Portola Pharmaceuticals I... Executive VP and CFO   •       –      –    2014-11-25 4 AS $28.23 $31,561 D/D (1,118) 0 0 -
PTLA Portola Pharmaceuticals I... Executive VP and CFO   •       –      –    2014-06-25 4 AS $28.52 $142,600 D/D (5,000) 11,118 0 -
PTLA Portola Pharmaceuticals I... EVP, CFO & CBO   •       –      –    2019-05-20 4 D $28.69 $86,701 D/D (3,022) 69,570 0 -
PTLA Portola Pharmaceuticals I... Interim Co-President & CFO   •       –      –    2018-09-04 4 D $29.18 $259,203 D/D (8,884) 98,800 0 -
  73  Records found
  1   2  3      
  Page 2 of 3  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us